Patents by Inventor Orest Olejnik

Orest Olejnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080009436
    Abstract: A composition is disclosed herein comprising from about 0.001% to about 0.
    Type: Application
    Filed: September 18, 2007
    Publication date: January 10, 2008
    Inventors: James Chang, Orest Olejnik, Bruce Firestone
  • Publication number: 20070270346
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Application
    Filed: June 12, 2007
    Publication date: November 22, 2007
    Inventors: Peter Bakhit, Richard Graham, Orest Olejnik
  • Patent number: 7297679
    Abstract: A composition comprising from about 0.001% to about 0.4% cyclosporin A, a surfactant, and an oil having a specific gravity from 0.8 to 0.95 is disclosed herein.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: November 20, 2007
    Assignee: Allergan, Inc.
    Inventors: James N. Chang, Orest Olejnik, Bruce A. Firestone
  • Patent number: 7288520
    Abstract: A composition is disclosed herein comprising from about 0.001% to about 0.
    Type: Grant
    Filed: October 19, 2005
    Date of Patent: October 30, 2007
    Assignee: Allergan, Inc.
    Inventors: James N. Chang, Orest Olejnik, Bruce A. Firestone
  • Publication number: 20070244051
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Application
    Filed: June 12, 2007
    Publication date: October 18, 2007
    Inventors: PETER BAKHIT, Richard Graham, Orest Olejnik
  • Patent number: 7276476
    Abstract: A composition comprising from 0.001% to about 0.4% cyclosporin A, a surfactant, and an oil selected from the group consisting of anise oil, clove oil, cassia oil, cinnamon oil, and combinations thereof, wherein said composition is an ophthalmically acceptable emulsion is disclosed herein.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: October 2, 2007
    Assignee: Allergan, Inc.
    Inventors: James N. Chang, Orest Olejnik, Bruce A. Firestone
  • Patent number: 7244768
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Grant
    Filed: August 25, 2004
    Date of Patent: July 17, 2007
    Assignee: Allergan, Inc.
    Inventors: Peter G. Bakhit, Richard Graham, Orest Olejnik
  • Publication number: 20070149447
    Abstract: A composition comprising a therapeutically effective amount of cyclosporin A, a blend of oils having a specific gravity of from 0.90 to 1.07, and a surfactant is disclosed herein.
    Type: Application
    Filed: February 28, 2007
    Publication date: June 28, 2007
    Inventors: James Chang, Orest Olejnik, Bruce Firestone
  • Publication number: 20070098773
    Abstract: A needleless microprotrusion system for infusion of a medicament into a patient includes a plurality of microprotrusions having a length sufficient to penetrate a stratum corneum of the patient. A chemodenervating agent is disposed for delivery by the microprotrusions and a substrate is provided for supporting the microprotrusions and conforming the microprotrusions to a patient's palm in order to enable uniform penetration of the microprotrusions into the corneum.
    Type: Application
    Filed: November 16, 2006
    Publication date: May 3, 2007
    Inventors: Orest Olejnik, Robert Lyons, Scott Gerondale
  • Publication number: 20070098774
    Abstract: A needleless microprotrusion method for infusion of a medicament into a patient includes disposing a substrate plurality of microprotrusions onto a patients' palm. A chemodenervating agent is disposed for delivery by the microprotrusions and the substrate supports and conforms the microprotrusions to the patients' palm in order to enable uniform penetration of the microprotrusions into the corneum.
    Type: Application
    Filed: November 16, 2006
    Publication date: May 3, 2007
    Inventors: Orest Olejnik, Robert Lyons, Scott Gerondale
  • Patent number: 7202209
    Abstract: A composition comprising a therapeutically effective amount of cyclosporin A, a blend of oils having a specific gravity of from 0.90 to 1.07, and a surfactant is disclosed herein.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: April 10, 2007
    Assignee: Allergan, Inc.
    Inventors: James N. Chang, Orest Olejnik, Bruce A. Firestone
  • Publication number: 20070066541
    Abstract: Membrane transporter-targeted therapeutic agents and methods of making and using the same.
    Type: Application
    Filed: September 15, 2006
    Publication date: March 22, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Patrick Hughes, Orest Olejnik, Joan-En Chang-Lin
  • Publication number: 20070042951
    Abstract: Disclosed herein are dosage forms comprising an alpha-2-adrenergic agonist and a trefoil factor family peptide. Related to these dosage forms are methods of treating glaucoma or reducing intraocular pressure and methods of treating gastrointestinal disorders.
    Type: Application
    Filed: August 26, 2004
    Publication date: February 22, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Orest Olejnik, Peter Bakhit, Richard Graham
  • Patent number: 7179482
    Abstract: An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: February 20, 2007
    Assignee: Allergan, Inc.
    Inventors: Orest Olejnik, Patrick M. Hughes, John S. Kent
  • Publication number: 20070031472
    Abstract: Biocompatible intraocular implants include a steroid and an auxiliary agent, where the auxiliary agent is present in an amount sufficient to lessen the severity of at least one side effect compared to the use of an otherwise identical implant lacking said auxiliary agent. The steroid and the auxiliary agent may be present on the same intraocular implant or on different implants. The steroid and auxiliary agent may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the steroid may be associated with a polymeric coating having one or more openings effective to permit the steroid to be released into an external environment. The implants containing the steroid and an auxiliary agent may be placed in an eye to treat one or more ocular conditions while reducing the side effects otherwise accompanying steroid use.
    Type: Application
    Filed: June 23, 2006
    Publication date: February 8, 2007
    Applicant: Allergan, Inc.
    Inventors: Glenn Huang, Thierry Nivaggioli, Lon Spada, Hiroshi Sugimoto, Wendy Blanda, James Chang, Orest Olejnik
  • Publication number: 20070015690
    Abstract: A composition comprising from about 0.001% to about 0.4% cyclosporin A, a surfactant, and an oil having a specific gravity from 0.8 to 0.95 is disclosed herein.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 18, 2007
    Inventors: James Chang, Orest Olejnik, Bruce Firestone
  • Publication number: 20070015692
    Abstract: A composition comprising a therapeutically effective amount of cyclosporin A, a blend of oils having a specific gravity of from 0.90 to 1.07, and a surfactant is disclosed herein.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 18, 2007
    Inventors: James Chang, Orest Olejnik, Bruce Firestone
  • Publication number: 20070015710
    Abstract: A composition comprising from 0.001% to about 0.4% cyclosporin A, a surfactant, and an oil selected from the group consisting of anise oil, clove oil, cassia oil, cinnamon oil, and combinations thereof, wherein said composition is an ophthalmically acceptable emulsion is disclosed herein.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 18, 2007
    Inventors: James Chang, Orest Olejnik, Bruce Firestone
  • Publication number: 20070015693
    Abstract: Cyclosporin A compositions are disclosed herein comprising an oil and a surfactant.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 18, 2007
    Inventors: James Chang, Orest Olejnik, Bruce Firestone
  • Publication number: 20070015691
    Abstract: A composition is disclosed herein comprising from about 0.001% to about 0.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 18, 2007
    Inventors: James Chang, Orest Olejnik, Bruce Firestone